Overview

Fenofibrate in Primary Biliary Cholangitis: a Real World Study

Status:
RECRUITING
Trial end date:
2035-12-01
Target enrollment:
Participant gender:
Summary
An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Fenofibrate in Combination with Ursodeoxycholic Acid in Subjects with Primary Biliary Cholangitis (PBC)
Phase:
PHASE3
Details
Lead Sponsor:
Xijing Hospital of Digestive Diseases
Treatments:
Fenofibrate